Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Introduction to 30 Years: Lessons Learned in Dialysis.

Seminars in dialysis

Nissenson AR, Mehrotra R.
PMID: 28155246
Semin Dial. 2017 Mar;30(2):85. doi: 10.1111/sdi.12578. Epub 2017 Feb 02.

No abstract available.

Cite
Nissenson AR, Mehrotra R. Introduction to 30 Years: Lessons Learned in Dialysis. Semin Dial. 2017;30(2):85doi: 10.1111/sdi.12578.
Nissenson, A. R., & Mehrotra, R. (2017). Introduction to 30 Years: Lessons Learned in Dialysis. Seminars in dialysis, 30(2), 85. https://doi.org/10.1111/sdi.12578
Nissenson, Allen R, and Mehrotra, Rajnish. "Introduction to 30 Years: Lessons Learned in Dialysis." Seminars in dialysis vol. 30,2 (2017): 85. doi: https://doi.org/10.1111/sdi.12578
Nissenson AR, Mehrotra R. Introduction to 30 Years: Lessons Learned in Dialysis. Semin Dial. 2017 Mar;30(2):85. doi: 10.1111/sdi.12578. Epub 2017 Feb 02. PMID: 28155246.
Copy Download .nbib Format: NLM
A 'quiet revolution' in nephrology.

Nephrology news & issues

Rettig R, Vargas R, Norris K, Nissenson AR.
PMID: 21189749
Nephrol News Issues. 2010 Nov;24(12):18-9, 23.

No abstract available.

Cite
Rettig R, Vargas R, Norris K, et al. A 'quiet revolution' in nephrology. Nephrol News Issues. 2010;24(12):18-9, 23
Rettig, R., Vargas, R., Norris, K., & Nissenson, A. R. (2010). A 'quiet revolution' in nephrology. Nephrology news & issues, 24(12), 18-9, 23.
Rettig, Richard, et al. "A 'quiet revolution' in nephrology." Nephrology news & issues vol. 24,12 (2010): 18-9, 23.
Rettig R, Vargas R, Norris K, Nissenson AR. A 'quiet revolution' in nephrology. Nephrol News Issues. 2010 Nov;24(12):18-9, 23. PMID: 21189749.
Copy Download .nbib Format: NLM
Hispanics with end-stage renal disease.

Annals of internal medicine

Radecki SE, Nissenson AR.
PMID: 7944091
Ann Intern Med. 1994 Nov 01;121(9):723-4. doi: 10.7326/0003-4819-121-9-199411010-00023.

No abstract available.

Cite
Radecki SE, Nissenson AR. Hispanics with end-stage renal disease. Ann Intern Med. 1994;121(9):723-4doi: 10.7326/0003-4819-121-9-199411010-00023.
Radecki, S. E., & Nissenson, A. R. (1994). Hispanics with end-stage renal disease. Annals of internal medicine, 121(9), 723-4. https://doi.org/10.7326/0003-4819-121-9-199411010-00023
Radecki, S E, and Nissenson, A R. "Hispanics with end-stage renal disease." Annals of internal medicine vol. 121,9 (1994): 723-4. doi: https://doi.org/10.7326/0003-4819-121-9-199411010-00023
Radecki SE, Nissenson AR. Hispanics with end-stage renal disease. Ann Intern Med. 1994 Nov 01;121(9):723-4. doi: 10.7326/0003-4819-121-9-199411010-00023. PMID: 7944091.
Copy Download .nbib Format: NLM
FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES.

Journal of renal care

Benner D, Nissenson AR, Van Wyck D.
PMID: 22085413
J Ren Care. 2011 Nov 15; doi: 10.1111/j.1755-6686.2011.00233.x. Epub 2011 Nov 15.

As with other disease states, mineral and bone disorder (MBD) management is challenging and may benefit from more systematic management. To evaluate the effectiveness of a focused campaign to improve MBD outcomes, we compared the percentage of patients meeting...

Cite
Benner D, Nissenson AR, Van Wyck D. FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES. J Ren Care. 2011;doi: 10.1111/j.1755-6686.2011.00233.x.
Benner, D., Nissenson, A. R., & Van Wyck, D. (2011). FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES. Journal of renal care, . https://doi.org/10.1111/j.1755-6686.2011.00233.x
Benner, Debbie, et al. "FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES." Journal of renal care vol. (2011). doi: https://doi.org/10.1111/j.1755-6686.2011.00233.x
Benner D, Nissenson AR, Van Wyck D. FOCUSED CLINICAL CAMPAIGN IMPROVES MINERAL AND BONE DISORDER OUTCOMES. J Ren Care. 2011 Nov 15; doi: 10.1111/j.1755-6686.2011.00233.x. Epub 2011 Nov 15. PMID: 22085413.
Copy Download .nbib Format: NLM
Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies.

Rand health quarterly

Rettig RA, Vargas RB, Norris KC, Nissenson AR.
PMID: 28083165
Rand Health Q. 2011 Mar 01;1(1):9. eCollection 2011.

This article describes a study that examines changes in nephrology as it evolves from a focus on end-stage renal disease (ESRD) to the treatment of earlier stages of chronic kidney disease (CKD). Once patients reach ESRD, treatments are limited...

Cite
Rettig RA, Vargas RB, Norris KC, et al. Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies. Rand Health Q. 2011;1(1):9
Rettig, R. A., Vargas, R. B., Norris, K. C., & Nissenson, A. R. (2011). Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies. Rand health quarterly, 1(1), 9.
Rettig, Richard A, et al. "Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies." Rand health quarterly vol. 1,1 (2011): 9.
Rettig RA, Vargas RB, Norris KC, Nissenson AR. Chronic Kidney Disease-A Quiet Revolution in Nephrology: Six Case Studies. Rand Health Q. 2011 Mar 01;1(1):9. eCollection 2011. PMID: 28083165; PMCID: PMC4945216.
Copy Download .nbib Format: NLM
Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson.

Drugs

Nissenson AR.
PMID: 11735637
Drugs. 2001;61(14):2105-2106. doi: 10.2165/00003495-200161140-00008.

No abstract available.

Cite
Nissenson AR. Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson. Drugs. 2001;61(14):2105-2106doi: 10.2165/00003495-200161140-00008.
Nissenson, A. R. (2001). Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson. Drugs, 61(14), 2105-2106. https://doi.org/10.2165/00003495-200161140-00008
Nissenson, Allen R.. "Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson." Drugs vol. 61,14 (2001): 2105-2106. doi: https://doi.org/10.2165/00003495-200161140-00008
Nissenson AR. Darbepoetin Alfa: A Viewpoint by Allen R. Nissenson. Drugs. 2001;61(14):2105-2106. doi: 10.2165/00003495-200161140-00008. PMID: 11735637.
Copy Download .nbib Format: NLM
Production of gas phase NO2 and halogens from the photolysis of thin water films containing nitrate, chloride and bromide ions at room temperature.

Physical chemistry chemical physics : PCCP

Richards-Henderson NK, Callahan KM, Nissenson P, Nishino N, Tobias DJ, Finlayson-Pitts BJ.
PMID: 24042539
Phys Chem Chem Phys. 2013 Oct 28;15(40):17636-46. doi: 10.1039/c3cp52956h.

Nitrate and halide ions coexist in particles generated in marine regions, around alkaline dry lakes, and in the Arctic snowpack. Although the photochemistry of nitrate ions in bulk aqueous solution is well known, there is recent evidence that it...

Cite
Richards-Henderson NK, Callahan KM, Nissenson P, et al. Production of gas phase NO2 and halogens from the photolysis of thin water films containing nitrate, chloride and bromide ions at room temperature. Phys Chem Chem Phys. 2013;15(40):17636-46doi: 10.1039/c3cp52956h.
Richards-Henderson, N. K., Callahan, K. M., Nissenson, P., Nishino, N., Tobias, D. J., & Finlayson-Pitts, B. J. (2013). Production of gas phase NO2 and halogens from the photolysis of thin water films containing nitrate, chloride and bromide ions at room temperature. Physical chemistry chemical physics : PCCP, 15(40), 17636-46. https://doi.org/10.1039/c3cp52956h
Richards-Henderson, Nicole K, et al. "Production of gas phase NO2 and halogens from the photolysis of thin water films containing nitrate, chloride and bromide ions at room temperature." Physical chemistry chemical physics : PCCP vol. 15,40 (2013): 17636-46. doi: https://doi.org/10.1039/c3cp52956h
Richards-Henderson NK, Callahan KM, Nissenson P, Nishino N, Tobias DJ, Finlayson-Pitts BJ. Production of gas phase NO2 and halogens from the photolysis of thin water films containing nitrate, chloride and bromide ions at room temperature. Phys Chem Chem Phys. 2013 Oct 28;15(40):17636-46. doi: 10.1039/c3cp52956h. PMID: 24042539.
Copy Download .nbib Format: NLM
Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients.

Kidney international supplements

Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K.
PMID: 25019031
Kidney Int Suppl (2011). 2013 Dec;3(5):462-468. doi: 10.1038/kisup.2013.96.

Elevated serum phosphorus is associated with higher death risk in hemodialysis patients. Previous studies have suggested that both higher serum parathyroid hormone (PTH) level and higher dietary protein intake may contribute to higher serum phosphorus levels. However, it is...

Cite
Streja E, Lau WL, Goldstein L, et al. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011). 2013;3(5):462-468doi: 10.1038/kisup.2013.96.
Streja, E., Lau, W. L., Goldstein, L., Sim, J. J., Molnar, M. Z., Nissenson, A. R., Kovesdy, C. P., & Kalantar-Zadeh, K. (2013). Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney international supplements, 3(5), 462-468. https://doi.org/10.1038/kisup.2013.96
Streja, Elani, et al. "Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients." Kidney international supplements vol. 3,5 (2013): 462-468. doi: https://doi.org/10.1038/kisup.2013.96
Streja E, Lau WL, Goldstein L, Sim JJ, Molnar MZ, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl (2011). 2013 Dec;3(5):462-468. doi: 10.1038/kisup.2013.96. PMID: 25019031; PMCID: PMC4089743.
Copy Download .nbib Format: NLM
Investigating the cellular origin of rotator cuff muscle fatty infiltration and fibrosis after injury.

Muscles, ligaments and tendons journal

Liu X, Ning AY, Chang NC, Kim H, Nissenson R, Wang L, Feeley BT.
PMID: 27331027
Muscles Ligaments Tendons J. 2016 May 19;6(1):6-15. doi: 10.11138/mltj/2016.6.1.006. eCollection 2016.

BACKGROUND: rotator cuff muscle atrophy, fibrosis and fatty infiltration are common complications after large and massive rotator cuff tears. Currently, there are no effective treatments for these muscle pathologies after injury. Furthermore, the cellular source for fibrotic and adipose...

Cite
Liu X, Ning AY, Chang NC, et al. Investigating the cellular origin of rotator cuff muscle fatty infiltration and fibrosis after injury. Muscles Ligaments Tendons J. 2016;6(1):6-15doi: 10.11138/mltj/2016.6.1.006.
Liu, X., Ning, A. Y., Chang, N. C., Kim, H., Nissenson, R., Wang, L., & Feeley, B. T. (2016). Investigating the cellular origin of rotator cuff muscle fatty infiltration and fibrosis after injury. Muscles, ligaments and tendons journal, 6(1), 6-15. https://doi.org/10.11138/mltj/2016.6.1.006
Liu, Xuhui, et al. "Investigating the cellular origin of rotator cuff muscle fatty infiltration and fibrosis after injury." Muscles, ligaments and tendons journal vol. 6,1 (2016): 6-15. doi: https://doi.org/10.11138/mltj/2016.6.1.006
Liu X, Ning AY, Chang NC, Kim H, Nissenson R, Wang L, Feeley BT. Investigating the cellular origin of rotator cuff muscle fatty infiltration and fibrosis after injury. Muscles Ligaments Tendons J. 2016 May 19;6(1):6-15. doi: 10.11138/mltj/2016.6.1.006. eCollection 2016. PMID: 27331027; PMCID: PMC4915463.
Copy Download .nbib Format: NLM
Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid.

Kidney medicine

Wigneswaran J, St Peter WL, Nissenson AR, Krishnan M, Faris R, Becker B, Lorch J.
PMID: 32734211
Kidney Med. 2019 Aug 20;1(5):307-314. doi: 10.1016/j.xkme.2019.06.008. eCollection 2019.

Patients with end-stage renal disease treated with dialysis are often prescribed complex medication regimens, placing them at risk for drug-drug interactions and other medication-related problems. Particularly in the context of a broader interest in more patient-centered value-based care, improving...

Cite
Wigneswaran J, St Peter WL, Nissenson AR, et al. Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid. Kidney Med. 2019;1(5):307-314doi: 10.1016/j.xkme.2019.06.008.
Wigneswaran, J., St Peter, W. L., Nissenson, A. R., Krishnan, M., Faris, R., Becker, B., & Lorch, J. (2019). Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid. Kidney medicine, 1(5), 307-314. https://doi.org/10.1016/j.xkme.2019.06.008
Wigneswaran, John, et al. "Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid." Kidney medicine vol. 1,5 (2019): 307-314. doi: https://doi.org/10.1016/j.xkme.2019.06.008
Wigneswaran J, St Peter WL, Nissenson AR, Krishnan M, Faris R, Becker B, Lorch J. Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid. Kidney Med. 2019 Aug 20;1(5):307-314. doi: 10.1016/j.xkme.2019.06.008. eCollection 2019. PMID: 32734211; PMCID: PMC7380411.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries